#IUCLS2023

Ultmann Chicago Lymphoma Symposium Agenda

Faculty slides approved for release are now available. Video Presentations will be be available soon!

Interprofessional Session

Welcome, Introductions, and Pre-session ARS

Morning Session #1

Bispecific Antibodies in Follicular Lymphoma – Julie Pruett, APNP

CAR T-Cells and Target agents in Follicular Lymphoma – Talha Khan, PharmD, BCOP

Audience Q&A

Sexual Health in the AYA Patient Population – Adam Duvall, MD, MPH

Audience Q&A and Post-session ARS

Break & Exhibits

Morning Session #2: How Would You Treat?

Pre-session ARS

Treatment Landscape in DLBCL – Tara McCabe, APN

DLBCL Patient Case Studies – Tara McCabe, APN and Rebecca Rosenbloom, RN, BSN

Panel discussion and Q&A

Treatment Landscape in CLL – Jennifer Boyer Greenfield, MSN, APRN, NP-C

CLL Patient Case Studies – Jennifer Boyer Greenfield, MSN, APRN, NP-C – Bianca Campanile, RN – Rachel Kraft, MSN, RN

Panel discussion, Q&A, and Post-session ARS

Session Wrap-Up

General Session

Welcome and Introductions

Mini Symposium on Biology of Lymphoma and the Immune Microenvironment

Pre-session ARS

From Cell of Origin to Mutational Landscape – Laura Hilton, PhD

Targeting Epigenetics – How Far Have We Come? – Ari Melnick, MD

Immune Microenvironment of Lymphoma – Stephen Ansell, MD, PhD

Panel discussion. Q&A and Post-session ARS

Break & Exhibits

Keynote Presentation: Evolution in the Classification of Lymphoma: From WHO to ICC – Where Do We Go From Here?

Mini Symposium on Imaging and ctDNA in Lymphoma

How Many Scans Are Too Many? – Carrie Thompson, MD

Are We Ready to Move Beyond Standard Imaging for Surveillance? MTV and Radiomics – Maryellen Giger, PhD

Are We Ready to Move Beyond Standard Imaging for Surveillance? ctDNA – Mark Roschewski, MD

Panel discussion, Q&A, and Post-session ARS

General Session Wrap-up

Welcome Reception with Exhibitors

General Session

Welcome and Introductions

Practical Strategies for Diversity, Equity, and Inclusion in Clinical Lymphoma Research - Ruemu Birhiray, MD

Mini Symposium on Hodgkin Lymphoma

Pre-session ARS

Frontline Approaches for Previously Untreated HL – Jonathan Friedberg, MD, MMSc

Treating Relapsed/Refractory HL – Ann LaCasce, MD, MMSc

Caring for Older/Comorbid Patients With HL – Andrew Evens, DO, MBA, MSc

Panel discussion, Q&A, and Post-session ARS

Break & Exhibits

20 Years of IUCLS

Pre-session ARS

A Look Back at 20 Years of IUCLS

“Dual” Keynote Symposium: A Look at the Advancement of Lymphoma Therapy Over the Last 20 Years

The Evolution of Novel Therapies in MCL – Michael Williams, MD

Incorporation of Bispecific Antibodies into Lymphoma Therapy – Nancy Bartlett, MD

“Dual” Keynote Symposium: Experts Debate the Role of Transplant in PTCL

Pro – Barbara Pro, MD / Con – Ranjana Advani, MD

Panel discussion, Q&A, and Post-session ARS

Lunch, Exhibits, and Meet the Professor Session

Mini Symposium on Transplant and Cellular Therapy

Pre-session ARS

DEBATE: CAR T-cell Therapy Should be Standard Therapy For All Patients with Early Relapsed DLBCL

Pro Transplant – Timothy Fenske, MD, MS | Pro CAR T – Jeremy Abramson, MD

Resistance to Cellular Therapy – Catherine Bollard, MD, MBChB

Panel discussion, Q&A, and Post-session ARS

Break & Exhibits

Mini Symposium on Follicular Lymphoma

Panel discussion, Q&A, and Post-session ARS

Historical Perspectives of FL – Leo Gordon, MD

Future Directions in the Treatment of FL – Brad Kahl, MD

Current Gaps of Treatment – Loretta Nastoupil, MD

Panel discussion, Q&A, and Post-session ARS

Summary and Best of IUCLS – CLS Chairs

Adjourn

Time (CST)

Friday, April 21

1:00 PM – 1:05 PM

Welcome and Introductions

1:05 PM – 2:30 PM

Mini Symposium on Biology of Lymphoma and the Immune Microenvironment

1:05 – 1:10 PM Pre-session ARS

1:10 – 1:30 PM: From Cell of Origin to Mutational Landscape
David Scott, MBChB PhD

1:30 – 1:50 PM: Molecular Monitoring of Lymphoma with ctDNA

1:50 – 2:10 PM: Immune Microenvironment of Lymphoma
Stephen Ansell, MD, PhD

2:10 – 2:30 PM: Panel discussion, Q&A, and Post-session ARS

2:30 PM – 2:50 PM

Break & Exhibits

2:50PM – 5:00 PM

Mini Symposium on Classification and Imaging in Lymphoma

2:50 – 3:50 PM: Keynote: Evolution in the Classification of Lymphoma: From WHO to ICC – Where do we go from here?

3:50 – 4:30 PM: PET Imaging in Lymphoma

3:50 – 4:10 PM: Historical Perspectives
4:10 – 4:30 PM: Future Directions

4:30 – 4:50 PM: How Many Scans are Too Many?
Carrie Thompson, MD, MS

4:50 – 5:10 PM: Panel discussion, Q&A, and Post-session ARS

5:10 PM

General Session Wrap Up and Summary

Time (CST)

Saturday, April 22

8:00 AM – 8:05 AM

Welcome and Introductions

8:00 AM – 8:25 AM

Practical Strategies for Diversity, Equity, and Inclusion in Clinical Lymphoma Research
Ruemu Birhiray, MD

8:25 AM – 9:50 AM

Mini Symposium on Hodgkin Lymphoma

8:25 – 8:30 AM: Pre-session ARS

8:35 – 8:55 AM: Frontline Approaches for Previously Untreated HL
Jonathan Friedberg, MD, MMSc

8:55 – 9:15 AM: Treating Relapsed/Refractory HL
Ann LaCasce, MD, MMSc

9:15 – 9:35 AM: Caring for Older/Comorbid Patients with HL
Andrew Evens, DO, MBA, MSc

9:35 – 9:50 AM: Panel discussion with speakers, Q&A, and post-session ARS

9:50 AM – 10:10 AM

Break & Virtual Exhibit

10:10 AM – 12:00 PM

20 Years of IUCLS

10:10 – 10:15 AM: Pre-session ARS

10:15 – 10:35 AM: A Look Back at 20 Years of IUCLS

10:35 – 11:15 AM: “Dual” Keynote Symposium: A Look at the Advancement of Lymphoma Therapy Over the Last 20 Years

The Evolution of Novel Therapies in MCL
Michael Williams, MD
Incorporation of Bispecific Antibodies into Lymphoma Therapy
Nancy Bartlett, MD

11:15 – 11:55 AM: “Duel” Keynote Symposium: Experts Debate the Role of Transplant in PTCL

Pro
Con – Ranjana Advani, MD

11:55 AM – 12:00 PM: Panel discussion, Q&A, and Post-session ARS

12:00 PM – 1:00 PM

Lunch & Exhibits

1:00 PM – 2:25 PM

Mini Symposium on Transplant and Cellular Therapy

1:00 – 1:05 PM: Pre-session ARS

1:05 – 1:25 PM: Where do Auto and Allo SCT Have a Role in Lymphoid Malignancies?

1:25 – 1:45 PM: Sequencing of CAR T-cell Therapy

1:45 – 2:05 PM: Resistance to Cellular Therapy
Catherine Bollard, MD, MBChB

2:05 – 2:25 PM: Panel discussion with speakers, Q&A, and post-session ARS

2:25 PM – 2:45 PM

Break & Virtual Exhibits

2:45 PM – 4:10 PM

Mini Symposium on Follicular Lymphoma

2:45 – 2:50 PM: Pre-session ARS

2:50 – 3:10 PM: Historical Perspectives of FL
Leo Gordon, MD

3:10 –3:30 PM: Future Directions in the Treatment of FL
Brad Kahl, MD

3:30 – 3:50 PM: Current Gaps of Treatment
Loretta Nastoupil, MD

3:50 – 4:10 PM: Panel discussion, Q&A, and Post-session ARS

4:10 – 4:30PM

Summary and Best of IUCLS

4:30 PM

Adjourn

Ultmann Chicago Lymphoma Symposium Agenda

Download Presentation

Watch Video

Download Presentation

Watch Video

Interprofessional Session

Morning Session #1

Morning Session #2: How Would You Treat?

General Session

Mini Symposium on Biology of Lymphoma and the Immune Microenvironment

Break & Exhibits

General Session Wrap-up

Welcome Reception with Exhibitors

Download Presentation

Watch Video

Download Presentation

Watch Video

General Session

Practical Strategies for Diversity, Equity, and Inclusion in Clinical Lymphoma Research - Ruemu Birhiray, MD

Break & Exhibits

Lunch, Exhibits, and Meet the Professor Session

Break & Exhibits

We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.

This website uses cookies to ensure you get the best experience on our website.